antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]

RxCUI: 1593156
RxNorm name: antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]
Display name: antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]
Full name: antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:13

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125512	Obizur	Antihemophilic Factor (Recombinant), Porcine Sequence	351(a)	Rx	2026-09-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a69ccbb3-7648-4978-8c6d-7ca6b95a9b01	OBIZUR 1 UNT Injection [PSN] · antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur] [SBD] · Obizur 1 UNT Injection [SY]	3	18	These highlights do not include all the information needed to use OBIZUR ® safely and effectively. See full prescribing information for OBIZUR. OBIZUR ® [Antihemophilic Factor (Recombinant), Porcine Sequence] Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2014	20250305